2345
We report the case of a 20-year-old female with polyarteritis nodosa (PAN) who developed bilateral sensorineural hearing loss 25 minutes after receiving 30 mg of intravenous ketoralac.
 20-year-old female with polyarteritis nodosa (PAN): Subject; 20-year-old: Subject.Age; female: Subject.Gender; bilateral sensorineural hearing loss: Effect; 30 mg of intravenous ketoralac: Treatment; polyarteritis nodosa: Treatment.Disorder; 25 minutes after: Treatment.Time_elapsed; 30 mg: Treatment.Dosage; intravenous: Treatment.Route; ketoralac: Treatment.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 20-year-old female with polyarteritis nodosa (PAN): Subject; 20-year-old: Subject.Age; female: Subject.Gender; bilateral sensorineural hearing loss: Effect; 30 mg of intravenous ketoralac: Treatment; polyarteritis nodosa: Treatment.Disorder; 25 minutes after: Treatment.Time_elapsed; 30 mg: Treatment.Dosage; intravenous: Treatment.Route; ketoralac: Treatment.Drug